Deerfield Management Company, L.P. (Series C) Alector, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Alector, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,055,192 shares of ALEC stock, worth $4.29 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,055,192

Previous 1,148,326 8.11%

Holding current value

$4.29 Million

Previous $5.21 Million 5.49%

% of portfolio

0.09%

Previous 0.11%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.34 - $6.58 $404,201 - $612,821	-93,134 Reduced 8.11%	1,055,192 $4.93 Million
Q2 2024 Aug 14, 2024	BUY	$4.19 - $6.23 $316,265 - $470,246	75,481 Added 7.04%	1,148,326 $5.21 Million
Q1 2024 May 15, 2024	BUY	$5.69 - $8.08 $28,649 - $40,682	5,035 Added 0.47%	1,072,845 $6.46 Million
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $47,569 - $105,865	12,618 Added 1.2%	1,067,810 $8.52 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $3.82 Million - $6.79 Million	-406,786 Reduced 27.82%	1,055,192 $16 Million
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $2.27 Million - $5.37 Million	-215,019 Reduced 12.82%	1,461,978 $15.4 Million
Q2 2020 Aug 14, 2020	SELL	$21.87 - $33.11 $1.36 Million - $2.05 Million	-62,000 Reduced 3.57%	1,676,997 $41 Million
Q1 2020 May 15, 2020	SELL	$16.25 - $35.28 $5.49 Million - $11.9 Million	-337,815 Reduced 16.27%	1,738,997 $42 Million
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $4.76 Million - $7.32 Million	329,889 Added 18.88%	2,076,812 $29.9 Million
Q2 2019 Aug 14, 2019	SELL	$16.26 - $26.42 $3.41 Million - $5.55 Million	-210,000 Reduced 10.73%	1,746,923 $33.2 Million
Q1 2019 May 15, 2019	BUY	$15.97 - $22.5 $31.3 Million - $44 Million	1,956,923 New	1,956,923 $36.6 Million

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $336M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account

Deerfield Management Company, L.P. (Series C) Alector, Inc. Transaction History